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CHAPTER I

LITERATURE REVIEW

In large domestic farm animals, quality of gametes,
nutrition, environmental factors, or the failure to
fertilize can all result in lower reproductive performance.
Vitamin A and retinoid metabolites are known to be involved

in reproductive processes (Takahashi et al., 1975; De Luca,
1991), but the mechanisms by which they function are not
fully understood.

Therefore, a greater understanding of the

mechanisms that occur during the reproductive process is of

value from an economic standpoint as well as contributing to
our overall knowledge for a process that occurs in all
animals.

Vitamin A

The major dietary sources of vitamin A are carotenoids

found in plants and retinyl esters found in animal tissues.
Once ingested, vitamin A becomes emulsified with lipids in
the stomach and travels to the intestine.

In the intestine,

retinyl esters are hydrolyzed to retinol and then are
reesterified during absorption.

Retinol and |8-carotene are

then solubilized in micelles in order to enter liver mucosal

cells where /3-carotene is converted to retinol in a reaction
involving 15-15•-dioxygenase (Olson, 1989).

Retinol is then

reesterified and stored in the lipid core of chylomicrons
within the parenchyitial cells of the liver and in stellate
cells as retinyl esters.

When vitamin A is needed, it is

hydrolyzed to retinol and secreted from the liver bound to
retinol-binding protein (RBP) in a 1:1 molar ratio (Kanai et
al., 1968; Goss and McBurney, 1992; Olson, 1989).

The underlying action of retinoids is to influence

cellular differentiation by inducing transcriptional
activity of specific genes.

Carcinoma stem cells (Breitman

et al., 1980; Strickland and Mahdavi, 1978) and endothelial

cells (Paige et al., 1991) have been known to differentiate
when treated with retinoic acid.

Further, the

transcriptional activity of several genes, parathyroid
hormone (Yasuda et al., 1989), transglutaminase (Chiocca et
al., 1988; Nara et al., 1989), growth hormone receptor

(Ohlsson et al., 1993), and cellular retinol-binding protein

I, or CRBP I (Plateroti et al., 1993) have been shown to be
affected by retinoic acid treatment resulting in either
induction or inhibition.

The ability of retinoids to induce cellular
proliferation has been less clear.

Low doses of vitamin A

in some studies induce proliferation, whereas in other

studies, proliferation is suppressed.

High doses of vitamin

A were also found to inhibit cellular proliferation (Lotan,

1980).

Daniel and coworkers (1991) found that j3-carotene

administered prior to calving enhanced lymphocyte

proliferation and suggested a role in protecting the mammary
gland from infection.

Recently, retinoids (specifically synthetic retinoid
analogs) have been used in cancer treatment (reviewed by
Sporn et al., 1976) due to their effects on cellular
proliferation and differentiation.

They also have been

recognized for their ability to act as free radical
scavengers (Tesoriere et al., 1993; Davison et al., 1993;
Olson, 1993; Bittrich et al., 1993).

Vitamin A in reproduction
Vitamin A and retinoid binding proteins have been found
in several extrahepatic sites.

Vitamin A metabolites were

found in bovine and porcine plasma, follicular fluid, and

corpora lutea by Chew and coworkers (1984) indicating a role
for vitamin A in reproduction.

Several studies have

confirmed that vitamin A-deficient animals or those with

marginal vitamin A intakes had pregnancies that resulted in
resorption, malformed fetuses, or decreased litter sizes
(Takahashi et al., 1975; Mason, 1935; Wilson and Warkany,
1949; Wilson et al., 1953).

Hypervitaminosis A may also

result in fetal resorption and fetal abnormalities (Pillans
et al., 1988; Kochhar, 1967; Lammer et al., 1985) due to the

toxic effects of retinoids at high concentrations.

Retinoic

acid has been implicated as the most potent naturally

occurring retinoid teratogen, but endogenous levels have

been detected in fetal tissues (Kraft and Juchau, 1993;
Kraft et al., 1993).

Neural crest cells have been suggested

as a major target for retinoic acid during embryonic
development (Dencker et al., 1990).

The adverse effects of

excess retinoic acid on embryonic development are varied and
extensive (Yasuda et al., 1989; Steele et al., 1983;

Thompson, 1969; Kraft and Juchau, 1993).

At physiological

concentrations, retinoic acid has been shown to induce

polarizing activity in the chick limb bud (Noji et al.,
1991), and to respecify pattern formation in the
regenerating axolotl limb (Keeble and Maden, 1984).

Retinol-binding protein
Serum RBP is initially synthesized in the liver as a

preRBP (molecular weight=24 kD) and cotranslationally
processed to a peptide with a molecular weight of
approximately 21 kD (Kanai et al., 1968, Soprano et al.,
1981).

It functions to transport retinol in the blood

(Kanai et al., 1968) and has been implicated as a buffer to

protect cells against the toxic effects of high levels of
retinol (Dingle et al., 1972).

during vitamin A deficiency.

RBP accumulates in the liver

The factors which regulate its

secretion are believed to be located in the endoplasmic
reticulum.

It has been shown that during retinol

deficiency, RBP secretion is blocked in the endoplasmic
reticulum before it can travel to the Golgi apparatus

(Soprano and Blaner, 1994; Smith and Goodman, 1979).
Plasma RBP has high amino acid sequence homology among

several species with greater than 90% identity between
human, bovine, and rabbit RBPs (Berni et al., 1990; Muto and

Goodman, 1972).

The major differences in the primary

structure of RBP among different species are located on the
surface of the molecule in the a-helix and the C-terminus.

The high degree of conservation of the amino acid sequence
may be due to the specific molecular interactions in which
RBP participates (Berni et al., 1990).
RBP has binding affinity for most retinoids, but has

highest affinity for retinol (Cogan et al., 1976).

It has

been suggested that an intact trimethylcyclohexenyl group
found on most retinoid compounds is responsible for binding

with RBP (Berni et al., 1993).

It is believed that retinol

must first bind RBP and this complex is then bound by

transthyretin (TTR).

In the reverse process in which

retinol is released, retinol dissociates from RBP-TTR and

then the RBP-TTR complex dissociates (Petersen, 1971; Noy et
al., 1992).

Retinol-binding protein exists in a liganded form,
holoRBP, or in an unliganded form, apoRBP.

The crystal

structure of bovine holoRBP has been determined and is

structurally almost identical to human holoRBP (Zanotti et
al., 1993a).

The structure of RBP consists of a single

domain which is composed of an N-terminal coil, eight

antiparallel j8-strands, an a-helix and a C-terminal coil.
Retinol binds at the jS-barrel site causing a conformational

change between the liganded and unliganded forms of RBP
which results in the rotation of the side chain of

Phenylalanine 36 toward the interior cavity of the |8-barrel.
This results in the displacement of the hydroxyl group of
retinol in apoRBP (Zanotti et al., 1993b).

RBP regulation in the liver

Most of our understanding of vitamin A and its
metabolites have come from classical experiments performed
in the rat.

Within the liver and blood, RBP levels have

been found to be controlled by retinoid status of the
animal.

Retinol must be present in order for RBP to be

secreted by the liver.

Vitamin A deficiency and depletion

in rats caused a decrease in serum RBP levels, and

concomitantly induced an increase in liver RBP levels as
compared to normal rats (Muto and Goodman, 1972; Muto et
al., 1972).

Furthermore, if the vitamin A-depleted rats

were supplemented with vitamin A, levels of RBP returned to
normal.

It has also been found that vitamin A-depleted rats

have a lower rate of retinol utilization (Green et al.,
1987).

Vitamin A status does not however regulate the

expression of RBP messenger ribonucleic acid (mRNA) within
the liver (Soprano et al., 1986a, Soprano et al., 1982).

Cellular retinoid-binding proteins
Within the cell, retinol is bound by cellular retinol-

binding protein I or II (CRBP I or II), and retinoic acid is
bound by cellular retinoic acid-binding protein I or II
(CRABP I or II).

The cellular retinoid-binding proteins

belong to a family of low molecular weight carrier proteins
which are found in most tissues (Wolf and Phil, 1991).

CRBP I (m.w.=15 kD) consists of 134 amino acids whose

sequence is highly conserved among species.

The tertiary

structure of CRBP I and CRBP II are similar as determined by
crystallographic studies (Ong et al., 1994).

CRBP II has a

molecular weight of approximately 16 kD and is composed of
134 amino acids (Ong, 1984; Ong et al., 1994).

Both

proteins bind retinol and retinal with high affinity,
however CRBP I binds retinol with a higher affinity than

retinal (Ong et al., 1994).

In addition to regulating RBP

secretion in the liver, it has been shown that secretion and

expression of CRBP I mRNA are influenced by retinoid status
(Plateroti et al., 1993; Kato et al., 1985; Rajan et al.,
1990).
Several functional roles have been identified for these

two proteins.

Ottonello and coworkers (1993) found that

retinol bound to CRBP I is used as a substrate for retinoic

acid synthesis within the liver.

In addition, CRBP I has

been found to direct retinol to liver microsomes for

esterification by an acyl-CoA independent enzyme reaction

(Yost et al., 1988).

CRBP II is tissue-specific, found

mostly within the intestinal mucosa (Ong, 1984).

Free

retinol undergoes esterification in the small intestine
under in vitro conditions, and retinol bound to nonspecific

serum proteins is esterified by an acyl-CoA;retinol
acyltransferase activity.

It is thought that in the in vivo

system, esterification proceeds via lecithin-retinol
acyltransferase when retinol is bound to CRBP II (Ong et
al., 1987; Helgerud et al., 1983; MacDonald and Ong, 1988).
It has been suggested that CRBP I and CRBP II play an

important role in controlling the concentration and the type
of retinoid found within a cell.

CRBP I is mainly found in

those tissues that require retinoic acid, while tissues
primarily expressing CRBP II may have a lower tolerance for
retinoic acid (Giguere, 1994).

Expression of transcripts

for CRBP and retinoic acid receptors (RARs) have also been
detected in the uterine endometrium of pigs, indicating that

CRBP may serve to facilitate the metabolism of retinol to
retinoic acid for interaction with RARs within the nucleus

(Harney et al., 1994a).
CRABP I and II differ in their N-terminal amino acid

sequence and each have highly conserved amino acid sequences
among different species (Ong et al., 1994).

The levels of

CRABP, in contrast to RBP and CRBP, have not been found to

be controlled by retinoid status (Kato et al., 1985).

The

functional role of CRABP has been linked to embryogenesis.

It was suggested by Keeble and Maden (1984) that CRABP may

be employed by retinoic acid to exert its action on pattern
formation in the regenerating axolotl limb.

Strong

expression of CRABP was found in embryonic tissues that are
colonized by neural crest cells, and Dencker and coworkers
(1990) postulated that another role for CRABP may be to

buffer the teratogenic effects caused by excess retinoic
acid.

Gene knockout studies have shown interesting results
for CRABP in mice.

CRABP I null mutant mice appear normal

and are indistinguishable from wild type mice (Gorry et al.,

1994).

Additionally, CRABP II mutant null mice also exhibit

normal development, fertility, and life span, except for a
limb malformation that is found to occur in approximately
50% of mutants.

There seems to be no increase in expression

of CRABP I or RAR transcripts in these CRABP II null mutant
forms.

Furthermore, CRABP I/CRABP II double null mutants

appear to be normal, but display a limb malformation similar
to the one mentioned above.

Double mutant mice exhibit the

same sensitivity to retinoic acid as wild type mice (Lampron
et al., 1995).

These studies demonstrated that CRABPs are

not intrinsically involved in the retinoic acid signalling
pathway.

Retinoic acid receptors

Retinoic acid receptors (RARs) and retinoid X receptors
(RXRs) are nuclear receptors that form homo- or heterodimers in order to bind to retinoic acid response elements

(RAREs) on target genes.

Many RAREs consist of a direct

repeat of a core sequence AGGTCA spaced by 1 to 5-base pairs
(Wan, 1993; Gudas, 1994).

RARs can bind all-trans retinoic

acid and 9-cis retinoic acid, whereas RXRs only bind 9-cis

retinoic acid (Chambon, 1994).

RAREs have been identified

on the laminin B1 gene in mice, and transcription can be
either induced or inhibited when receptor complexes bind to
the RAREs (Vasios et al., 1989).

MacDonald and coworkers

(1994) found that parathyroid hormone expression is

suppressed by retinoic acid which may occur via RARs or
RXRs.

Currently, three RARs (a, jS, and 7) have been
identified and multiple isoforms of each type exist

(reviewed by Giguere, 1994).

RARs consist of an N-terminus,

a ligand-binding domain, a DNA-binding domain, a central
region, and a C-terminus.

The isoforms of each RAR differ

in the N-terminal region (Chambon, 1994).

Each of the RARs

contains an RARE in their promoter region which indicates
that RARs are retinoic acid responsive genes.

The tissue

distribution for the transcripts of each RAR varies; RARa is
found in most tissue types, RAR/3 distribution is more
restricted and found in abundance in the central nervous
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system, and RAR7 is mainly found in the skin and lungs
(Giguere, 1994).

In addition, RARs were localized in the

uterus and ovary of several species (Zhuang et al., 1994).

During embryonic development and in adult forms,

differential expression of the individual RARs exists

suggesting that each RAR has a specific function (Yamagata
et al., 1994; Giguere, 1994; Kato et al., 1992).

The level

of RAR/? transcripts in rat tissues is regulated at the

transcriptional level by retinoid status, whereas expression
of RARa and 7 mRNA does not seem to be as sensitive to
retinoids (Kato et al., 1992; Harnish et al., 1992).

Several studies involving gene knockouts of the various
RARs and their respective isoforms have been performed.
RAR/S null mutants appear and develop normally (Mendelsohn et

al., 1994; Luo et al., 1995).

In contrast, mutant mice

lacking RARa or 7 do not develop normally, and have reduced

viability despite a normal appearance, suggesting that the
retinoic acid signal is transduced through RARa and 7

(Chambon, 1994; Lohnes et al., 1993).

These studies have

led several authors to suggest that a functional redundancy

exists among RARs; if a particular RAR is lacking, another
RAR can take over and perform its function (Chambon, 1994;
Giguere, 1994; Luo et al., 1995)

To date, three RXRs (a, jS, and 7) have been identified,

but only RXR7 has been shown to have more than one isoform
(Giguere, 1994).

The RXRs and RARs vary quite considerably
11

in "their amino acid sequences.

The RXR prcteins also

consist of a DNA-binding domain and a ligand-binding domain

and vary from each other in their N-terminus (Mangelsdorf et

al., 1994).

RXRs a and

are ubiquitously expressed, while

the distribution of RXR7 is more restricted (Giguere, 1994).
Gene knockouts for the RXRs have revealed that the RXRa null

mutation is embryonic lethal, suggesting that RXRa is
crucial during embryonic development (Kastner et al., 1994).
RXRs have been shown to form either hetero- or homodimers

with a number of nuclear receptors in order to mediate
retinoic acid actions, indicating a role of the RXRs to

create several pathways for retinoid signaling (Giguere,
1994).

RBP membrane receptors

The existence of a membrane receptor for RBP for
internalization of retinol into a cell has been somewhat

controversial.

While some investigators have found cells

displaying cell-surface RBP binding activity, there has not
been a thorough biochemical characterization of an RBP
membrane receptor.

The most characterized membrane receptor has been found

in the retinal pigment epithelium, which binds RBP in a 1:1
molar ratio.

This protein has been described as having a

molecular weight of approximately 63 kD (B^vik et al.,1992).

Furthermore, the gene for this receptor appears to be highly
12

conserved among several species (B^vik et al., 1993).
Additionally, high binding activity for REP has been
localized in the placenta, bone marrow, and kidneys, and
lower binding activity exists in the small intestine,
spleen, liver, lung, and testis (Smeland et al., 1995).

Uterine RBP

The secretions of the uterus, or histotrophe, have a
role in nutrition and in directing growth and development of
the conceptus during pregnancy (Roberts and Bazer, 1988).
These secretions are synthesized by the surface and

glandular epithelium of the uterine endometrium (Roberts et
al., 1993).

In the uterus, RBP has been identified as a

component of histotrophe (Roberts and Bazer, 1988).
The porcine uterine RBP has been found to be identical
to serum RBP immunologically and by amino acid sequence

analysis (Stallings-Mann et al., 1993).

In cyclic pigs,

expression of RBP mRNA was low or undetectable in the early
to midluteal phase, increased during the late luteal phase,
and decreased thereafter to the end of the estrous cycle.
Pregnant gilts, on the other hand, maintain the increase in

RBP mRNA expression, suggesting that the gene for RBP is

regulated by progesterone (Harney et al., 1993).

During

pregnancy, RBP has been localized in the surface and

glandular epithelium of the uterine endometrium (Harney et
al., 1990).

Ovariectomized gilts treated with progesterone
13

showed an increase in uterine secretion of RBP compared to
those receiving corn oil vehicle alone (Adams et al., 1981).

Furthermore, treatment of ovariectomized gilts with

progesterone on days 3-16 and with estrogen on days 1-2 and
13-14 increased RBP expression, suggesting that estrogen

secreted by elongating conceptuses may serve to increase
uterine RBP expression as well as the signal for maternal
recognition of pregnancy (Trout et al., 1992; Harney et al.,
1994b).
Similar results have been obtained in the ovine and

bovine species for the regulation of uterine expression of
RBP.

Bovine RBP has been characterized as a protein with a

molecular weight of 21 kD consisting of several isoelectric
variants (Liu and Godkin, 1992).

The uterine species of RBP

in the bovine shares complete sequence homology with
placental and plasma RBP over the first 25 amino acids.
Levels of RBP in uterine flushes of cows were elevated

during midcycle, and barely detectable early and late in the
estrous cycle, but remained elevated during early pregnancy
(Liu and Godkin, 1992; Dore et al., 1995).

Expression of

RBP transcripts in cyclic cows declines early in the estrous

cycle and reaches low levels on days 7-10, and then rises
and peaks during proestrus (day 20).

Furthermore, RBP mRNA

expression is similar in pregnant and cyclic cows during
diestrus, but levels of RBP mRNA in pregnant animals
increase from day 17 to day 22 and remain elevated
14

thereafter through day 36 of pregnancy (MacKenzie et al.,
1994).

Studies involving primary luteal phase uterine

epithelial cell cultures have shown that retinol and
estrogen each cause an increase in RBP secretion, while
retinoic acid and progesterone have no effect (Dore et al.,

1995).

Additionally, uterine concentrations of RBP are

enhanced in ovariectomized cows by progesterone treatment

(Thomas et al., 1992).

Uterine RBP has been localized in

the apical regions of surface epithelium and in the luminal
regions of glandular epithelium suggesting that RBP may be
secreted from the surface epithelium into the uterine lumen
(Liu and Godkin, 1992).
Endometrial expression of RBP mRNA was elevated during

midcycle in both cyclic and pregnant ewes and remained
elevated in cyclic ewes, but decreased in pregnant ewes
during the late luteal phase (days 14-16) (Harney et al.,
1993).

However, Dore and coworkers (1994) found RBP

expression decreased from day 13 to day 16 in cyclic ewes,
again suggesting control of RBP expression may be regulated
by progesterone.

Both authors suggested the decrease in RBP

expression of day 16 pregnant ewes could be regulated by

conceptus secretory products.

After the decrease seen in

RBP mRNA on day 16 in pregnant ewes, RBP transcript levels
are stabilized through day 30 (Dore et al., 1994).

15

Conceptus RBP

Another extrahepatic site of retinoid-binding proteins
and of vitamin A that has recently been investigated is
fetal tissues.

Retinoic acid has been detected in second

trimester fetal tissues of humans (Kraft et al., 1993), and

seems to target neural crest cells and neural crest-derived
tissues during fetal development in mice (Dencker et al.,
1990).

In the rat, expression of RBP and TTR has been found in
the fetal liver.

In addition, the visceral yolk sac

contained these transcripts.

Explants of this tissue

synthesized and secreted RBP and TTR (Soprano et al.,
1986b).

Expression of RBP increased from day 7 to 9 of

development (Makover et al., 1989), while RBP protein

concentrations remained low.

A very high molar ratio of

vitamin A:RBP was observed during this time (Takahashi et
al., 1977).
1989), and

RBP increased from days 11-14 (Makover et al.,
CRABP expression was maximal during this period

(Dencker et al., 1990).

The molar ratio of vitamin A:RBP

decreased to approximately 1 between days 11 and 14
suggesting that vitamin A may have been transported to the

conceptus independently of RBP earlier, but forms a complex
with RBP on days 11-14 (Takahashi et al., 1977).

Soprano

and coworkers (1988) found that by day 14, the visceral yolk
sac and fetal liver both synthesize and secrete RBP.

Availability of vitamin A seems to play a role in the
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regulation of conceptus RBP in the rat yolk sac similar to
that seen in the liver.

In a retinol-depleted state, the

visceral yolk sac and fetal liver have greatly elevated
levels of RBP, and repletion of retinol causes RBP levels to

return to normal.

In addition, RBP mRNA expression in the

retinol-depleted tissues was not affected (Soprano et al.,
1988).

Takahashi and coworkers (1977) suggested that

maternal retinol-RBP can cross the uterine-placental barrier
from dam to fetus early in gestation.
Porcine conceptus RBP (pcRBP) has been found to have a

molecular weight of 21 kD and to be identical to porcine
serum RBP as determined by amino acid sequence analysis
(Trout et al., 1991).

Harney and coworkers (1994a) have

found that pcRBP can bind retinol and retinoic acid in
vitro, but has a higher affinity for retinol.

In addition

to RBP, porcine conceptuses express CRBP and RAR genes

during the peri-implantation period of pregnancy.

Secretion

of RBP by conceptuses in culture increases between days 10
and 15 of pregnancy (Harney et al., 1990), and high levels
of RBP mRNA have been detected in the day 15 conceptus

(Harney et al., 1994b).

Two other important events coincide

with this time frame: the period of rapid elongation and

maternal recognition of pregnancy which is signaled by
secretion of estrogen by the conceptus (Roberts and Bazer,

1988).

RBP mRNA was detected in the inner cell mass of day

11 spherical conceptuses (Trout et al., 1991).
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In addition,

RBP was detected in the trophectodera and yolk sac of day 15

conceptuses and in allantoic fluid from day 30 of pregnancy
(Harney et al., 1990).

Conceptus RBP in cows is also thought to be identical
to plasma RBP as determined by amino acid sequence analysis
and shares high sequence homology with pcRBP (Liu et al.,
1990; Liu et al., 1993).

Secretion of RBP by bovine embryos

seems to be developmentally regulated in that RBP is
detected in tissues and is synthesized and secreted by day
13 conceptuses that have elongated, but not by spherical day

13 conceptuses.

During the period of elongation, RBP has

been localized mainly within the trophectoderm (Liu et al.,

1993).

In situ hybridization studies have shown bovine

placental RBP (bpRBP) to be a product of the chorion,
allantois, and amnion.

It has been located in the

epithelial lining of these membranes, at days 45 and 135 of
gestation (Gao et al., 1991; Liu et al., 1993).

RBP has

been immunolocalized in the basal and spinosum cell layers
of day 160 amnion (Liu et al., 1994).

Liu and coworkers

(1990) found a low molar ratio of retinol:bpRBP, however it
was not determined whether this occurred in vivo or was due

to purification processes.

The protein profile of secreted proteins for ovine
conceptuses closely resembles that of bovine conceptuses,
however there are distinct temporal differences (Bartol et
al., 1985; Godkin et al., 1988).
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For example, the

production of bTP-1 is twice as long in duration than oTP-1
production (Godkin et al., 1982).

However it is reasonable

to postulate that secretion of RBP by the ovine conceptus
may be similar to that of the bovine conceptus.

RBP has

been detected at all time points examined during pregnancy
and is therefore probably produced throughout pregnancy in

both species (Liu et al., 1992; Liu et al., 1993).

As in

porcine and bovine conceptuses, secretion of ovine conceptus
RBP (ocRBP) increased between day 13 and day 16 (Dore et

al., 1994; Liu et al., 1992) which coincides with blastocyst

elongation (Bindon, 1971) and maternal recognition of

pregnancy (Godkin et al., 1982).

At this time, ocRBP has

been immunolocalized in the trophectoderm (Liu et al.,

1992).

Placental RBP has been detected in the chorion,

allantois, amnion, and yolk sac during the first trimester

of ovine (Liu et al., 1991; Liu et al., 1992) and caprine
conceptuses (Liu et al., 1995).

In the goat, RBP has been

immunolocalized in the trophectoderm of the chorion, the
endoderm of the allantois, and the ectoderm of the amnion

(Liu et al., 1995).

N-terminal sequence analysis of the

first 34 residues indicates ovine placental RBP shares

complete homology with bovine placental and plasma RBP and

extensive homology with porcine conceptus and human plasma
RBP (Liu et al., 1992).

Similarly, caprine placental RBP

shares complete amino acid sequence homology with bovine

plasma RBP and extensive homology with caprine and bovine
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placental RBP over the first 15 amino acids (Liu et al.,
1995).

At day 23 of gestation, ovine placental RBP is a

major protein product and transcript (Dore et al., 1994; Liu
et al., 1991).

Donoghue and coworkers (1982) found that the

carrier protein for the retinol-RBP complex in sheep was
different in fetal circulation than in the adult; either TTR
is modified or retinol-RBP forms a complex with another

protein in the fetal circulation.

As with bpRBP, a low

molar ratio of retinolropRBP was found suggesting RBP may be
secreted in an apo- form (Liu et al., 1992).
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CHAPTER II

REGULATION OF RETINOL-BINDING PROTEIN SECRETION BY RETINOIDS
IN THE OVINE CONCEPTUS

Abstract

During early pregnancy in sheep, implantation occurs
relatively late and fetal-maternal interactions are critical
to maintenance of pregnancy, embryonic survival and
development.

Reproductive processes are mediated in part by

conceptus secretory proteins and uterine proteins.

Vitamin

A (retinol) plays a role in reproductive processes and must
be present in precise amounts for normal embryonic
development.

Most retinol is stored in the liver and

transported bound to retinol-binding protein (RBP).

Within

the liver, the levels of RBP are regulated by retinoid
status.

Previous studies have suggested that placental RBP

may be secreted in an apo- form by the conceptus in order to
buffer the teratogenic effects of retinoids.

The purpose of

this study was to determine if retinoids influence RBP
secretion by the conceptus and to determine if conceptus RBP

is secreted in an apo- or holo- form.

Day 14 ovine

conceptuses were obtained from uterine flushes and cultured
in Dulbecco's minimal essential medium (DMEM) for 24 and 48

hours with addition of retinoids (10

all-trans retinol, 1

or 10 fM all-trans retinoic acid) in order to evaluate the
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effects of retinoid treatment on secretion and synthesis of
RBP by the conceptus.

Concentration of RBP was determined

by an enzyme linked immunosorbant assay (ELISA) in culture
medium and solubilized conceptus tissues.

Retinol

concentration of control conceptus cultures (no addition of
retinoids) was analysed by extracting culture medivim and
quantifying retinol-associated fluorescence of the extracts.
There were no differences in RBP concentration due to

treatments in either the culture medixim or conceptus
tissues.

Retinol was undetectable in the medium of control

conceptus cultures.

The results of this study demonstrate

regulation of RBP in the conceptus may be different than

that of the liver since physiological doses of retinoids did
not have an effect on RBP secretion or synthesis in the day
14 ovine conceptus.

The failure to detect retinol in medium

of control conceptus cultures indicates that either RBP is
secreted in an apo- form or retinol concentrations were

below the sensitivity of the assay.

Introduction

In sheep, implantation is not fully completed until the

fourth or fifth week of gestation, and definitive attachment
of the trophoblast to maternal tissues is not intiated until
about Day 15 (Boshier, 1969).

At approximately day 13 of

gestation, the conceptus undergoes a period of rapid
elongation and changes in form from a spherical to
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threadlike form (Bindon, 1971).

During elongation, the

conceptus initiates secretion of proteins in high
concentrations (Godkin et al., 1982; Masters et al., 1982).
The major secretory protein, interferon-T (IFN-t), is now

recognized as the conceptus antiluteolytic factor which is
responsible for maintaining luteal function during early
pregnancy (Godkin et al., 1982; Bazer et al., 1986).

IFN-t

inhibits luteolysis by down-regulating estrogen and oxytocin
receptors which cause the episodic secretion of

prostaglandin Fj^ (PGFj^), thereby extending progesterone
secretion by the corpus luteum (Spencer et al., 1995b).
This period of time is therefore a crucial stage in
development for the conceptus.

RBP is first synthesized and secreted during the

expansion period, but its regulation is not understood (Dore
et al., 1994; Liu et al., 1992).

RBP has been localized in

the trophectoderm of preimplantaion stage ovine embryos, and
it is secreted throughout much of pregnancy (Liu et al.,
1992).

Vitamin A is necessary for normal pregnancy and

embryonic development (Takahashi et al., 1975; Mason, 1935;
Wilson and Warkany, 1949; Wilson et al., 1953), however,
excess vitamin A can lead to fetal malformations or

resorption (Pillans et al., 1988; Kochhar et al., 1967;
Lammer et al., 1985).

Therefore RBP secretion by the

conceptus may function to distribute an appropriate amount
of retinol to conceptus tissues.
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Retinol is stored mainly within the liver and secreted

bound to RBP (Kanai et al., 1968).

RBP secretion in the

liver is controlled by retinoid status; retinol is necessary
for RBP to be secreted.

In a vitamin A-deficient state, RBP

increases in the liver, while circulating levels in blood
decrease.

Upon retinol repletion, both liver and blood

levels of RBP return to normal (Muto and Goodman, 1972).

Hepatic expression of RBP messenger ribonucleic acid (mRNA)
is not, however, regulated by dietary intake of vitamin A
(Soporano et al., 1986a; Soprano et al., 1982).

Ovine placental RBP (opRBP) has a molecular weight of
23 kD and is synthesized by the trophectoderm during
blastocyst elongation and well into pregnancy (Liu et al.,
1991; Liu et al., 1992).

Mechanisms which control RBP

production by the conceptus are unknown.

Secretion of RBP

by the fetal yolk sac in rats is similarly controlled by
retinoid status; secretion is inhibited in a vitamin A-

deficient state and returns to normal upon retinol repletion

(Soprano et al., 1988).

The purpose of this study was to

determine if RBP secretion by the day 14 conceptus is
affected by retinoids and whether conceptus RBP is secreted
in an apo- or holo- form.

Previous studies in our

laboratory have resulted in the discovery of a low molar
ratio of retinol:RBP, but it was not determined whether RBP

was secreted in an apo- form or if bound retinol had been

lost during the purification process of RBP (Liu et al.,
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1992).

Materials and Methods

Culture medium supplies and buffers were purchased from
GibcoBRL (New York).

Culture dishes were obtained from

Becton Dickinson (Lincoln Park, NJ).

Microtiter plates (96

well) were obtained from Corning (Corning, NY).
was purchased from Bio-Rad (Hercules, CA).

Conjugate

The p-

nitrophenylphosphate (p-NPP) phosphatase substrate was
obtained from Kirkegaard & Perry Laboratories (Gaithersburg,
MD).

Triton X-100 was scintillation grade and purchased

from Amersham (Arlington Heights, IL).

Protein assay

reagents were obtained from Pierce (Rockford IL).

The

Superose-12 column was purchased from Pharmacia (Uppsala,

Sweden).

^H-Retinol was obtained from NEN Research Products

(Wilmington, DE).

o-Xylene was purchased from Baxter.

All

other reagents were purchased from Sigma (St. Louis, MO).

Collection of Embryos:
0) with an intact ram.

Sheep were bred at estrus (Day

On day 14 of pregnancy, ewes were

anesthetized, placed in a dorsal recombinant position and
the uterus exteriorized through a midventral incision.

The

uterus was gently flushed by clamping the cervix with
intestinal forceps.

A catheter was inserted in the

contralateral uterine horn.

Twenty ml Hank's buffered

saline solution (HBSS) was injected into the uterine horn

ipsilateral to the corpus luteum (CL), and the medium and
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conceptus gently flushed around the uterine body and out

through the catheter and collected in a small glass bottle.
In most cases, a second 20 ml flush was performed to ensure
the entire embryo had been collected.

The contents of the

bottle were transported to the laboratory within 15 minutes.
Embryos were washed in HBSS and transferred to 35 X 10mm

culture dishes containing 5 ml of a Dulbecco's modified

minimum essential medium with treatments (Godkin et al.,
1988) and cultured for 24-48 hours.

Treatments were

prepared in ethanol and consisted of all-trans retinol (10
fiK), all-trans retinoic acid (1 or 10 /xM), and controls (no
addition of retinoids).

Retinoid treatments were performed

under subdued lighting due to the light-sensitivity of these
compounds.

Medium was removed after 24 hours and replaced

with fresh culture medium and treatment, and the conceptus
was cultured for an additional 24 hours.

Uterine flushes

and culture medium were centrifuged (2500 rpm) to remove
cellular debris, the supernatant transferred to tubes
wrapped in aluminum foil, and frozen at -80°C for analysis.
Conceptus tissues were retained in the same manner.
ELISA:

An ELISA was performed on the conceptus culture

medium and the solubilized conceptus tissues to quantitate
RBP.

ELISA buffers are shown in Appendix 1.

Standards were

prepared from purified serum RBP (Liu et al., 1990) ranging
from 0.1-10 ng/well and stored at -20°C.

Microtiter plates

were coated with RBP at a concentration of 20 ng/well and
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allowed to incubate overnight in a humidified chamber at
4®C.

The antigen-coated plates were washed with wash buffer

using a Dynatech Ultrawash II Microplate Washer (Chantilly,
VA), tapped dry, and stored in a sealed bag with dessicant

at -20°C.

Standards and diluted samples were mixed with a

bovine placental RBP antibody (anti-bpRBP) (Liu et al.,
1990) to a final dilution of 1:10,000 in 12 X 75mm
borosilicate glass test tubes and allowed to incubate

overnight at 4°C.

The following morning, the sample-anti-

bpRBP mixtures were transferred to the antigen-coated plate
and incubated in a humidified chamber at 30°C for 2 hours.

The plate was washed and tapped dry.

Goat anti-rabbit IgG

alkaline phosphatase conjugate was diluted 1:3,000 in room
temperature diluent and transferred to the wells and
incubated in a humidified chamber at 30°C for 2 hours.

wells were washed and tapped dry.

The

p-NPP phosphatase

substrate was prepared according to the manufacturer's

directions (Kirkegaard & Perry Laboratories, Gaithersburg,
MD).

Substrate was added to wells and incubated at 30®C in

a humidified chamber until the 100% antibody wells (antigencoated control wells with anti-bpRBP only) reached an
optical density of approximately 0.8-0.9 when read at an

absorbance of 405 nm.

At that time, 5% NajEDTA was added to

the wells to stop the reaction and the plate was read at an
absorbance of 405 nm on a BioTek Automated Microplate Reader

(Winooski, VT) to calculate the results.
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The intra-assay

variation was <5% and the inter-assay variation was <10%.
DNA Assay:

Cell lysis - Conceptus tissues were

solubilized by adding 1 ml of 1% Triton.

Cells were

vortexed % hour, incubated at 40°C 1 hour, vortexed % hour,
incubated at 40®C 1 hour, vortexed 2 hours, frozen overnight
at -80®C, thawed the next day, and then centrifuged to
pellet out cellular debris.

The supernatant was drawn off

for DNA analysis.
Procedure - Calf thymus DNA standards ranging from 01000 ng/ml and samples were prepared in buffer (150 mM NaCl,
5 mM HEPES, pH 7) and analyzed in triplicate in 1.5 ml

eppendorf tubes.

Six fil 4,6-Diamidino-2-phenylindole (DAPI)

was added to the standards and samples (114 ^1) at a final
concentration of 200 ng/ml and these mixtures were
transferred to a microtiter plate.

All procedures involving

DAPI were performed under subdued lighting because it is

light-sensitive.

After wells were loaded with the sample+

and standard+DAPI mixtures, fluorescence was determined
using a Millipore Cytofluor 2350 (Bedford, MA) with
excitation maximum set at 360 nm and emission maximum at 460

nm.

The intra-assay variation was <5%.
Protein Assay #I:

Conceptus culture medium - The

Pierce Coomassie Protein Assay Reagent was used to determine
total protein in conceptus culture medium.

Directions for

the Micro Assay Procedure using the Microtiter Plate Formula
was followed according to the manufacturer's directions.
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Briefly, bovine serum albumin (BSA) protein standards

ranging from 0-25 #tg/ml and samples were prepared in
triplicate in 10 mM Tris buffer, pH 7.6, in 12 X 75mm
borosilicate glass tubes.

The Coomassie Protein Assay

Reagent was mixed with standards or samples in a 1:1 ratio
(volume;volume) to a final volume of 700 fil.

Samples (200

fil/vBll) were transferred to a microtiter plate and
absorbance was read on a platereader at 595 nm.

The protein

concentration of the samples was determined from the
standard curve obtained by plotting absorbance vs. standard
concentration.

The intra-assay variation was <5%.

Protein Assay #2:

Conceptus tissues - Because Triton

interferes with the Coomassie Blue Dye assay described

above, protein concentrations of the conceptus tissues were
determined using the Pierce MicroBCA Protein Assay Reagent

Kit following the Microtiter Plate Protocol.

Briefly, BSA

protein standards were prepared ranging from 0-50 /xg/ml, and
samples were diluted in HEPES buffer (150 mM NaCl, 5 mM

HEPES, pH 7).

Samples and standards were mixed in a 1:1

ratio (volume:volume) with the MicroBCA Protein Assay
Reagent to a final volume of 700 ^1 in 12 X 75mm

borosilicate glass tubes, and then transferred in triplicate
to a microtiter plate (200 /tl/well).
and incubated at 60°C for 1 hour.

The plate was covered

The cover was removed,

and the plate was read on a platereader at an absorbance of
570 nm.

Sample protein concentrations were determined from
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a standard curve constructed by plotting absorbance vs.

protein standard concentrations.

The intra-assay variation

was <5%.

HPLC:

Conceptus culture medium was chromatographed on

a Superose-12 column utilizing an LKB HPLC unit (Bromma,
Sweden) to determine the concentration of retinol-bound RBP
by following the procedure of Trout and coworkers (1992).
The elution buffer was 1.5 M NaCl, 0.02 M Tris-HCl, 0.02%
azide, pH 8.2, and the flow rate was set at 0.5 ml/min for

all chromatography.

To determine the elution position of

RBP, 1 ml of purified RBP was dried in a Savant Speed-Vac

Concentrator (Farmingdale, NY) and resuspended in 300 /xl of
deionized water, 250 /lcI of which was submitted to column
chromatography with protein being monitored at 280 nm.

One

ml of sample (conceptus culture media) was dried, prepared
and chromatographed on the column as before.

The two

elution profiles were compared to find a common peak,

however there were several peaks in common.

The next step

was to run several protein standards on the column to obtain
a standard curve by plotting fraction # vs. log of the
molecular weight of protein standards.

The following were

used as protein standards:

7-globulin,

mol. wt. 150,OOODaltons

ovalbumin,
carbonic anhhydrase,
cytochrome C,
soybean trypsin
inhibitor,

mol. wt.
mol. wt.
mol. wt.

43,000 Daltons
31,000 Daltons
29,000 Daltons

mol. wt.

20,000 Daltons

j8-galactosidase,
pig albumin,

mol. wt. 116,250 Daltons
mol. wt. 67,000 Daltons
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myoglobin,

mol. wt.

15,500 Daltons

lysozyme,

mol. wt.

14,400 Daltons

The standard curve obtained was not very satisfactory,

especially in the range of the lower standard molecular
weights which was the area of interest.

Therfore, a new

elution buffer of lower salt concentration (0.15 M NaCl,

0.02 M Tris-HCl, 0.02% azide, pH 8.2) was prepared and used
in the remainder of the experiment.

The protein standards

were rechromatographed, but the same standard curve was

obtained.

Another option was tried in which conceptus

culture medium was dried down, prepared as before, and run
on the column with the fractions being analyzed by ELISA
(described earlier).
eluted fractions.

RBP was not detected in any of the

Next, several fractions suspected to be

associated with the RBP peak were run on a one-dimensional

sodixim dodecyl sulfate polyacrylamide gel electrophoresis
(ID-SDS-PAGE, 12%) followed by Coomassie Brilliant Blue
staining according to the Mini-Protean II Dual Slab Cell
Instruction Manual (Richmond, CA).

Again RBP protein bands

were not detected in the lanes loaded with the sample
fractions.

Alternatively, purified RBP was incubated with

retinol, dried, prepared as before, and chromatographed on
the HPLC column.

Fractions were collected in foil-wrapped

tubes, and several fractions were read on a TKO 100
Dedicated Mini Fluorometer (Hoefer Scientific Instruments,

San Francisco, CA) to determine if a peak of retinol
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fluorescence coincided with a peak on the protein elution
profile.

There was no fluorescence peak associated with the

fractions.

A final attempt to determine the elution

position of RBP was made by incubating purified RBP with 'Hretinol.

^H-Retinol and the RBP-^H-retinol mixture were both

chromatographed on the column and the protein absorbance
peaks were compared with the radioactivity peaks and RBP was
determined to elute at fractions 31-33.

Several samples of

each treatment (1 ml each) were dried, resuspended in 300 fil
deionized water, and 200 ^1 was chromatographed with protein
monitored at 280 nm.

These runs were performed in subdued

lighting and fractions 29-33 were collected in glass tubes
and wrapped in aluminum foil.

These fractions were

subsequently analyzed by a Perkin Elmer Luminescence
Spectrometer LS50B, with excitation wavelength set at 378 nm
and emission wavelength set at 455 nm.
Retinol Extraction and Ouantitation:

Retinol

concentrations in uterine flushes and control conceptus
culture medium were to be determined by fluorescence

analysis after xylene extraction using a procedure similar
to that of Selvaraj and Susheela (1970).

This entire

procedure was performed in subdued lighting.

Retinol

standards were prepared in medium ranging from 0-1.0 ^g/ml.
Extraction of retinol from culture medium samples was

performed by adding 1 ml of 95% ethanol to 1 ml standard or
sample.

After vortexing, tubes were placed in a 60®C heater
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block for 20 minutes, and then allowed to cool.

Xylene (1.8

ml) was added to the tubes and vortexed for 20 seconds.

The

tubes were centrifuged for approximately 2 minutes to

separate the 2 layers and the upper xylene layer containing
retinol was transferred into a separate glass tube.

Fluorescence was determined by a Baxter Schimadzu
Spectrofluorometer at an excitation wavelength of 325 nm and
emission wavelength of 480 nm.

A standard curve was

prepared by plotting standard retinol concentrations vs.
fluorescence.

For the uterine flushes, 5 ml of 95% ethanol were added

to 5 ml standard or sample in a glass tube and vortexed.
The tubes were incubated at 60°C for 20 minutes and allowed

to cool.

Six ml of xylene were added to the tubes and

vortexed for 20 seconds.

The layers were allowed to

separate and the upper xylene layer was transferred to

another glass tube.

Fluorescence of standards and samples

was determined the same as for the conceptus culture medium
described above.

Statistical Analysis:

Amount of conceptus REP per

amount of total conceptus cellular or total conceptus

secreted protein was analyzed for effects of treatment, day,

and treatment by day interactions.

The experimental design

was a completely randomized design and data were analyzed by
the General Linear Models procedure of SAS (SAS, 1990).

Means were separated by Fisher's least significant
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difference test.

Data was log transformed when necessary.

Significance was considered at the 95% confidence level.

Results

RBP Secretion by Ovine Embryos:

The raw values for RBP

in culture medixim and in conceptus tissues are shown in
Tables 1-la, 1-lb, and 1-lc and Table 1-2, respectively.

In

order to determine the amount of RBP secreted per amount of

conceptus tissue, RBP values were standardized with the
total amount of conceptus protein or with the total amount
of secreted conceptus protein.

Initially, RBP values were

to be standardized with the total DNA content of the

conceptus, but Triton, in which conceptus tissues were
solubilized, interferes with the DNA assay (data not shown).
There were no differences due to treatments or treatment by

day interaction in the amount of secreted RBP and the amount

of RBP in conceptus tissues whether standardized by the
total amount of secreted protein (TSP) (Table l-3a, l-3b,

and l-3c) or by the total amount of protein in conceptus
tissues (TCP) (Table l-4a, l-4b, and l-4c).

There was no

effect of day when RBP secretion was standardized with TCP

(Table l-4d), but there was a significant difference in the
amount of RBP secreted by the conceptus from day 1 to day 2
when RBP values were standardized with TSP (Table l-3d).
RBP in Conceptus Tissues:

There were no differences in

the amount of RBP within conceptus tissues when expressed as
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a percentage of the total amount of protein in conceptus
tissues (Table 1-5).
Determination of apo- and holo-RBP:

HPLC fractions

containing RBP were analyzed to determine if the fractions
were associated with fluorescence characteristic of retinol.
No fluorescence was detected in the fractions.

Retinol extraction and quantitation:

No fluorescence

was detected in the uterine flushes or control conceptus
culture medium after being subjected to extraction.

Tedsle 1-la. Raw RBP Concentration Secreted by Day 14 Ovine
Conceptus in Culture Medium on Day 1 of Culture.
Treatment

RBP in culture medium

N

(ng/ml)
Control

16

65.888+/-6.146*

Retinol

14

70.717+/-6.571'

l^M RA

12

65.793+/-7.097'

lO^M RA

5

47.242+/-10.995*

•Mean+/-S.E.; no significant differences found P>0.05.

Table 1-lb. Raw RBP Concentration Secreted by Day 14 Ovine
Conceptus in Culture Medium on Day 2 of Culture.
Treatment

RBP in culture medium

N

(ng/ml)
Control

16

68.445+/-6.146*

Retinol

14

66.054+/-6.571''

l^M RA

12

62.788+7-7.097*

10/iM RA

5

40.289+/-10.995*

*Mean+/-S.E.; no significant differences found P>0.05.
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Table 1-2. Raw RBP Concentration in Conceptus Tissues of
Day 14 Ovine Conceptus at End of 48 Hour Culture Period.
Treatment

N

RBP in conceptus tissues
(ng/ml)

Control

15

106.422+/-14.122'

Retinol

13

163.750+/-15.169*

ljuM RA

12

lOfiK RA

5

127.827+/-15.789*^
82.655+/-24.460'^

*''''®Mean+/-S.E.;values with different superscripts
are significantly different p<0.05.

Table l-3a.

RBP Secretion by Day 14 Ovine Conceptus due to

Treatment as % Total Protein (TSP) in Culture Medium on Day

1 of Culture.
Treatment

N

RBP as % TSP in culture medivim

(ng RBP/ng TP X 100)
Control

15

0.297+/-0.04*

Retinol

12

0.229+/-0.05''

1/xM RA

12

0.235+/-0.04''

10/xM RA

5

0.172+/-0.07''

•Mean+/-S.E.; no significant differences found P>0.05.

Table l-3b. RBP Secretion by Day 14 Ovine Conceptus due to

Treatment as % TSP in Culture Medium on Day 2 of Culture.
Treatment

N

RBP as % TSP in culture medium

(ng RBP/ng TP X 100)
Control

12

0.680+/-0.05*

Retinol

11

0.525+/-0.05*

1/xM RA

9

0.578+/-0.06*

10/iiM RA

6

0.680+/-0.05*

•Mean+/-S.E.; no significant differences found P>0.05.
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Table l-3c.
Day

RBP Secretion by Day 14 Ovine Conceptus as %
RBP as % TSP in culture medium

N

(ng RBP/ng TSP X 100)
1

44

0.233+/-0.03''

2

38

0.578+/-0.03''

■''^ean+/-S.E.; values with different superscripts
are significantly different p<0.001.

Table l-4a.
RBP Secretion by Day 14 Ovine Conceptus due to
Treatment as % Total Protein (TCP) in Conceptus Tissues on
Day 1 of Culture.
Treatment

N

RBP as % TCP in conceptus tissues

Control

16

0.0228+/-0.003''

Retinol

14

0.0201+/-0.003*

l^M RA

12

0.0259+/-0.003*

10/xM RA

5

0.0293+/-0.005''

(ng RBP/ng TCP X 100)

•Mean+/-S.E.; no significant differences found P>0.05.

Table l-4b. RBP Secretion by Day 14 Ovine Conceptus due to
Treatment as % TCP in Conceptus Tissues on Day 2 of Culture
Treatment

N

RBP as % TCP in conceptus tissues

Control

16

0.0286+/-0.003'

Retinol

14

0.0175+/-0.003*

ImM RA

12

0.0249+/-0.003''

10/xM RA

5

0.0266+/-0.005*

(ng RBP/ng TCP X 100)

"Mean+Z-S.E.; no significant differences found P>0.05.
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Table 1-4c.

RBP Secretion by Day 14 Ovine Conceptus as %

TCP in Conceptus Tissues on Day 1 and Day 2 of Culture.
Day

RBP as % TCP in conceptus tissues

N

(ng RBP/ng TCP X 100)
1

47

0.0245+/-0.002'

2

47

0.0244+/-0.002*

•Mean+/-S.E.; no significant differences found P>0.05.
Table 1-5. RBP in Conceptus Tissues of Day 14 Ovine
Conceptus due to Treatment as % TCP in Conceptus Tissues
During 48 Hour Culture Period.
Treatment

N

RBP as % TCP in conceptus tissues
(ng RBP/ng TCP X 100)

Control

15

0.0547+/-0.009*

Retinol

13

0.0482+/-0.009*

1/iM RA

12

0.0505+/-0.010'

10/xM RA

5

0.0583+/-0.015*

*Mean+/-S.E.; no significant difference found P>0.05.

Discussion

This study examined the role of retinoids in RBP
secretion in the Day 14 ovine embryo.

The period between

days 13 and 15 is crucial for the developing conceptus and
many important events occur at this time.

Embryo elongation

is initiated between days 12 and 14 (Bindon, 1971) and

proteins begin to be synthesized and secreted.

Of major

importance, ovine IFN-t (oIFN-t), the protein responsible
for maintenence of early pregnancy, is secreted at this time
and RBP secretion also begins to occur during this period of
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time.

Because implantation is not completed until the

fourth or fifth week of gestation (Boshier, 1969), there is
no intimate contact between maternal and fetal tissues at

day 14 of gestation.
Vitamin A, while necessary for normal development, can

be embryotoxic at high concentrations so that the regulation
of RBP is of major importance to the survival of the
conceptus during early gestation.

Liu and coworkers (1990)

have previously determined that the molar ratio of
retinol:RBP found in placental tissue cultures was low,
indicating that RBP was secreted in the apo- form.

However,

it was not concluded whether this was a natural phenomena or
an artifact that occurred during the purification of RBP.

Initially, it was hypothesized that retinoids may cause RBP
secretion to be elevated in order to buffer the teratogenic
effects of these compounds.

Clearly the results of this

study have shown that retinoid treatment does not affect RBP
secretion in the ovine conceptus at Day 14 of gestation.
It is well established that retinol is necessary for
RBP secretion in the liver.

The results of this study have

shown that RBP secretion was not different in retinoid-

treated embryos compared to controls leading to the
conclusion that neither retinol nor retinoic acid affect RBP

secretion by the conceptus as in the liver.

There are

several points to consider though before this conclusion can
be made.

First, the experimental design of this study was
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not identical to those performed in the liver, in that the
conceptus cultures were not vitamin A-deficient.

Soprano

and coworkers (1986a) fed rats a vitamin A-deficient diet
for 8 weeks before rats were considered to be retinol-

depleted as determined by serum retinol concentrations.

Perhaps if the ewes had been fed a diet deficient in vitamin
A, then the embryos could have been considered retinoldepleted and retinoid treatment may have effected different
results in RBP secretion.

However, as mentioned previously,

animals maintained on a vitamin A-deficient diet are likely

to have pregnancies that result in resorbed or malformed
fetuses.

Second, it is possible that vitamin A may regulate RBP
secretion in the conceptus and that retinol-depletion could
be carried out to determine this possibility.

Soprano and

coworkers (1988) found that RBP secretion, as in the liver,
was inhibited in a retinol-deficient state in the rat

visceral yolk sac at Day 14 of gestation.
returned to normal upon retinol-repletion.

Secretion of RBP
The dams in this

study were maintained in a good state of health, and fetuses
were considered normal since embryo resorption due to

vitamin A-deficiency does not occur in rats until Day 16 of
gestation.

In the liver, retinoids do not affect the level of

expression of RBP mRNA.

Several studies have found that

excess retinol or retinoic acid elevates the level of
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expression of retinoic acid receptor j8 messenger ribonucleic
acid (RARjS mRNA), but physiological doses have no effect
(Harnish et al., 1990; Harnish et al., 1992).

The RARjS gene

has been found to have a retinoic acid response element

(RARE) and therefore retinoic acid can induce expression of
RARjS mRNA, however this induction is cell specific and does

not occur in all cell types when treated with retinoic acid
(Davis and Lazar, 1993).
gene.

No RARE has been found on the RBP

Retinoids were administered at physiological

concentrations in this study.

It may be interesting to see

what effect teratogenic doses of retinoids have on RBP
secretion in the ovine embryo.

In conceptus cultures

treated with lO/xM RA, the raw RBP values were decreased,

which may have been due to cell death since this
concentration of retinoic acid may be somewhat toxic to the
embryo.

There was no effect due to any of the variables on

RBP values except for day when RBP secretion was expressed

as a percentage of the total protein secreted by the

conceptus.

In this case, RBP was significantly greater on

the second day of culture when compared to the initial day
of culture.

This occurred simply because the total amount

of protein secreted by the conceptus decreased considerably
on the second day of the experiment but RBP secretion
remained the same.

In order to determine if RBP was secreted predominently
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in an apo- or holo- form, retinol concentrations were to be
determined to calculate the molar ratio of RBP:retinol.

The

retinol assay did not detect retinol in the conceptus
cultures.

This could be due to the fact that no retinol was

present in the conceptus culture media, that the retinol in
the culture media had been lost due to degradation, or that
the level of retinol present in the media was below the

sensitivity of the assay.

The degradation of retinol while

being stored is not provided as a possible explanation for
the absence of retinol in the analyses since Comstock and
coworkers (1993) found that retinol is stable for up to four

years when stored at -70°C.

Back calculation of retinol

concentrations in control culture medium from corresponding
RBP concentrations, assuming a 1:1 molar ratio of retinol to
RBP, indicates that the levels of retinol could have been

below the level of sensitivity of the assay used in this

experiment.

However, this also means it is possible that

RBP could have been secreted in an apo- form.
In conclusion, RBP plays a crucial role in regulating

the delivery of retinol to the developing conceptus, however
the mechanism of control of RBP secretion in the conceptus

is not understood.

The present finding that RBP protein

levels were not affected by physiological doses of retinoid
treatments indicates that secretion of RBP by the ovine

conceptus at Day 14 of gestation does not increase in order
to protect itself from the potentially toxic effects of
42

vitamin A metabolites when added in physiological
concentrations.

However the in vitro studies employed here

may not reflect the in vivo situation.

Further studies to

determine if teratogenic concentrations of retinoids have

any effect on the secretion of RBP in the ovine conceptus
would be of interest.
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CHAPTER III

REGULATION OF RETINOL-BINDING PROTEIN MESSENGER

RIBONUCLEIC ACID EXPRESSION BY THE SEX STEROIDS IN
OVINE UTERINE ENDOMETRIUM

Abstract

Vitamin A has been shown to play an integral role in
reproductive processes, however it must be present within a
defined range.

Excess or deficiency in vitamin A may cause

fetal malformations and resorption.

In the liver, retinol

is stored and secreted in a 1:1 molar ratio bound to

retinol-binding protein (RBP).

Secretion of RBP in the

liver is regulated by retinoid status.

Recently, several

extrahepatic sites of RBP have been identified, including
the uterus.

RBP secretion by the uterine endometrium is

thought to be regulated, in part, by steroid hormones.

In

the present study, ovariectomized ewes were treated with

steroids in order to induce estrus (designated day 0) and
then randomly assigned to the following treatments:
progesterone (P), estrogen (E), or estrogen+progesterone

(EP).
IS.

Treatments were administered from day 1 to days IB

Blood samples were taken on days 3, 10, and the day of

hysterectomy in order to determine circulating levels of the
hormones.

Hysterectomies were performed on the final day of

treatment or on day 1 in the case of day 1 controls (Dl).
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Total uterine endometrial ribonucleic acid (RNA) was

isolated and slot blot analysis was performed to quantify
steady state RBP messenger RNA (mRNA) expression using an
RBP cDNA probe.

The results obtained from this study

indicate that RBP mRNA expression in P-treated ewes is

significantly higher than in C ewes (P<0.05), and E
treatment tended (P<0.16) to be lower than C.

Previous

studies have found that uterine RBP mRNA expression in
cyclic ewes decreases at the beginning of the luteal phase
(day 5) when progesterone is secreted by the corpus luteum

(CL).

Expression of RBP increases to maximal level late in

the luteal phase (day 13, 14) which coincides with

progesterone receptor down-regulation.

Expression either

remains elevated, or begins to decrease during the
follicular phase (days 15-16).

These results support the

theory that progesterone inhibits endometrial expression of
RBP mRNA, and that long-term exposure to progesterone

slightly stimulates RBP expression due to down-regulation of
the progesterone receptor.

Introduction

Uterine secretions prepare a suitable uterine
environment in which to receive an embryo.

Steroid hormones

are believed to play a role in this preparation by

regulating the secretions of the uterus, which are commonly
known as histotrophe.

The secretions of the uterus nourish
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the developing conceptus prior to implantation.
Vitamin A is essential for reproductive processes.
Vitamin A deficiency (Takahashi et al., 1975; Wilson et al.,

1953) or excess (Pillans et al., 1988; Kochhar, 1967; Lammer
et al., 1985) during pregnancy can result in fetal

resorption or malformations.

Therefore the amount of

retinol that the conceptus is exposed to must be carefully
regulated.
Most retinol is stored in the liver and is secreted in

a 1:1 molar ratio bound to RBP (Kanai et al., 1968; Goss and
McBurney, 1992; Olson, 1989).

RBP secretion by the liver is

dependent upon dietary vitamin A intake; retinol is
necessary for RBP secretion.

Hypovitaminosis A causes

levels of RBP to be elevated within the liver and decreases

circulating levels of RBP in the blood by inhibiting RBP
secretion from the liver.

Upon retinol repletion, hepatic

RBP concentration decreases to normal levels, and plasma
concentrations of RBP become elevated due to an increase in

hepatic RBP secretion (Muto and Goodman, 1972).

Recently, several extrahepatic sites, including the
conceptus and the uterus, have been found to synthesize and
secrete RBP (Harney et al., 1993; Dore et al., 1994; Soprano

et al., 1986b; Liu and Godkin, 1992; Liu et al., 1990; Liu
et al., 1991).

In the uterus, secretion of RBP is thought

to be progesterone-induced.

The concentration of RBP in

uterine flushings of ovariectomized gilts and cows treated
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with progesterone is elevated (Adams et al., 1981; Thomas et

al., 1992).

Endometrial expression of RBP mRNA is elevated

during the mid and late luteal phases in cyclic ewes which
coincides with maximal progesterone secretion (Harney et
al., 1993; Dore et al., 1994).

This experiment was designed

to evaluate effects of ovarian steroid hormones on

endometrial expression of RBP mRNA.

Materials and Methods

Microtiter plates (96 well) were obtained from Corning

(Corning, NY).
(Hercules, CA).

Conjugate was purchased from Bio-Rad
The p-nitrophenylphosphate phosphatase (p-

NPP) substrate was obtained from Kirkegaard & Perry
Laboratories (Gaithersburg, MD).

Silicons tubing was

purchased from Baxter (McGaw Park, IL).

Silicons sealant

was purchased from Dow Corning (Midland, MI).

Guanidine

isothiocyanate (GTC), 4M, was prepared according to the

methods of Sambrook and coworkers (1989), with Trizma Base,
EDTA, and N-lauryl sarcosine all obtained from Sigma (St.
Louis, MO).

Cesium trifluoroacetate (CsTFA), was prepared

following the manufacturer's directions to a have a specific

gravity of 1.51 and obtained from Pharmacia (Uppsala,
Sweden).

S & S Nytran membrane and the Minifold II slot-

blot system were purchased from Schleicher & Schuell (Keens,

NH). a^^P-dCTP and t^^P-ATP were obtained from ICN (Costa
Mesa, CA).

All other reagents were purchased from Sigma
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(St. Louis, MO).
TrGafzment of animals:

Ewes were ovariectoniized at

least 6 weeks prior to the experiment to remove any effects

of endogenous steroids.

A steroid replacement regime

developed by Romanics and Silvia (1988) was followed to
induce estrus, except that progesterone was administered for
8 days instead of 4 as follows;

Amount of hormone

Days before

Time

P4 (mg)*

estrus

E2 (/xg)"

10

SAM

12

-

9

SAM

12

-

8

SAM

12

-

7

SAM

12

-

6

SAM

12

-

5

SAM

12

-

4

SAM

12

-

3

SAM

12

-

2

4PM

—

3.5

—

7.0

—

14.0

—

7.0

-

3.5

12AM
1

SAM
4PM

12AM
0

•Administered in corn oil vehicle (4.0 mg/ml).
•"Administered in corn oil vehicle (7.0 /xg/ml).
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Ewes were checked for signs of behavioral estrus (designated
day 0) on the day following steroid treatment.

Ewes were

randomly assigned to the following treatment groups:
progesterone (P) (12 mg/day, i.m.), estrogen (E)

administered via silastic implants (3 cm long, 3.35 mm inner
diameter, 4.65 mm outer diameter) filled to capacity with

estradiol-17i8, estrogen and progesterone (EP) (12 mg/day P4,
i.m.+silastic implant containing estradiol-176), day 1
controls (Dl) (ewes that were hysterectomized on the first
day (day 1) after behavioral estrus with no further steroid

treatment), and controls (C) (ovariectomized ewes receiving
no steroid treatment).

Treatment was administered from day

1 to day 13-16 at which time the uterus was flushed with PBS
and then surgically removed.

Blood samples were taken on

days 3, 10, and prior to hysterectomy to determine
peripheral circulating concentrations of progesterone and

estradiol-17/3 by a validated RIA.

The RIA for estradiol-17j8

wa validated by Howard and coworkers (1990) and had 10%

cross-reactivity with dehydroisoandrosterone and less than
1% cross-reactivity with all other steroids analyzed.

The

RIA for progesterone was validated by Jackson and coworkers
(1989).
RNA Isolation:

Total RNA was isolated from the uterine

endometrium in GTC according to Dore and coworkers (1994).

Briefly, endometrium, containing both caruncular and
intercaruncular tissue was isolated from the uterus by
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dissection, homogenized in GTC buffer (4M) and then
ultracentrifuged on a CsCl/TFA bed for 24 hours at 25,000rpm
at 20°C to obtain a pellet of RNA.

Ethanol (70%, RNAse-

free) was added to wash the and then poured off.

The RNA

pellet was resuspended in 0.4% SDS (500 ^1) and stored at
-100»C.

RNA Formaldehyde Gel:

To determine whether uterine RNA

samples were intact, an RNA formaldehyde gel (1% agarose)
was run.

Absorbance of samples was read on a Beckman

Spectrophotometer DU 640 to determine RNA concentrations.
Each sample was prepared for electrophoresis as follows;
20 ng sample RNA

0.02 M 3-[N-morpholino]propanesulfonic acid (MOPS)
50% formamide

2.2 M formaldehyde

Prior to loading, samples were heated at 65®C for 10 minutes
to denature RNA, then loaded and run on the gel.

The gel

was stained with 0.5 jug/ml ethidium bromide in IX Tris
borate, or TEE (0.09M Tris-borate, 0.002M EDTA, pH 8.3), and
destained in IX TEE.

Slot Blot Analysis:

Steady state uterine REP mRNA was

quantified by slot blot analysis.

The probe was a bovine

conceptus REP cDNA clone (Liu et al., 1993).

Twenty fig of

total RNA were applied to a nylon membrane with a Minifold
slot blot apparatus following the manufacturer's

instructions (Schleicher and Schuell).

RNA was crosslinked

to the membrane by UV irradiation (1.6 joules/cm^).
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The

membrane was prehybridized (Appendix 2) in a sealed plastic
bag at 42®C for 4 hours.

The membrane was then hybridized

(Appendix 2) in a sealed plastic bag with the RBP probe,

prepared by random prime labelling with a^^P-dCTP to a

specific activity of 1.16 X lO' cpm//ig DNA, at 42°C for 24
hours.

The membrane was subjected to high-stringency

washing (Appendix 3) and then exposed to Kodak X-Omat AR
film for approximately 70 hours at -80°C.

The membrane was

stripped of the RBP probe by gently boiling in 0.1% SDS for
15 minutes and reprobed with a jS-actin cDNA probe, prepared
by random prime labelling to a specific activity of 1.38 X

lO' cpm//xg DNA as described previously for the RBP probe, to
correct RBP values for loading error.

Slot blot signal

intensities were determined by computer assisted scanning
laser densitometry using an LKB Ultrascan XL Enhanced Laser
Densitometer (Bromma, Sweden).

Slot blot sample signals

were integrated and the area for each sample was calculated
in arbitrary absorbance units (GSXL version 2 software,
LKB).

Sample areas were corrected for differences in total

RNA loaded onto the membrane through use of the

corresponding area from 6-actin or oligo dT autoradiographs.

Because temporal expression of /3-actin seemed to change
during the estrous cycle, the membrane was also reprobed
with oligo dT to correct for loading error.

was stripped of the /3-actin probe.

The membrane

The oligo dT probe was

prepared by random prime labelling with 7'^P-ATP to a
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specific activity of 3.43 X 10* cpin//xg DNA.

The membrane

was prehybridized (Appendix 4) for 2% hours at 50"C in
roller bottles.

The membrane was then hybridized (Appendix

4) with the oligo dT probe.

After high-stringency washing

(Appendix 5), the membrane was exposed to film for
approximately 2 hours at -SO^C, and relative expression of
RBP was determined as described above.

Steady state levels of uterine endometrial RBP mRNA

were then determined by slot blot analysis using 10 ng total
RNA instead of 20 ng.

Twenty-five /xg is the maximum amount

of total RNA that can be applied to the nylon membrane used

in this procedure.

Therefore, since expression of RBP mRNA

is fairly abundant in the uterus, 20 /xg may overload the
membrane and produce results outside the linear range of the
membrane, therefore 10 fj.g of total RNA was used to obtain

results that were well within the limits of this system.
Ten /xg total RNA from uterine endometrium was applied to a
nylon membrane with a slot blot apparatus as described
before.

The RBP probe was prepared by random prime

labelling with a*^P-dCTP to a specific activity of 2.77 X 10®
cpm//xg DNA.

The membrane was prehybridized (Appendix 6) for

at least 4 hours at 65°C in roller bottles.

The membrane

was then hybridized (Appendix 6) with the RBP probe at 42°C
for 18 hours in roller bottles.

The membrane was subjected

to high-stringency washes (Appendix 7) and then exposed to
Kodak X-Omat AR film for approximately 40 hours at -80®C.
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The membrane was stripped of the RBP probe and reprobed with
an oligo dT probe prepared by random prime labelling to a

specific activity of 1.67 X 10® cpm//ig DNA as described
previously to correct for loading error.

The membrane was

exposed to Kodak film as before and relative expression of
RBP mRNA was determined as desribed above.
Statistical Analysis:

Amounts of RBP in uterine

flushes and relative quantities of RBP mRNA per equivalent
amount of total RNA were analyzed for effect of treatment.

A completely randomized design was the experimental design
and data were analyzed by the General Linear Models
procedure of SAS (SAS,1990).

Means were separated by

Fisher's least significant difference test.

transformed when necessary.

Data was log

Significance was considered at

the 95% confidence level unless otherwise stated.

Results

Steroid concentrations of blood samples:

P4 and E2

concentrations were measured in plasma of blood taken from

the jugular vein during the treatment period.

Table 2-1

shows P4 concentrations due to treatment on the day of

hysterectomy.

P4 concentrations were consistent with luteal

P4 concentrations (>lng/ml) in the P and EP treatment groups
and lowest (P<0.05) in the Dl, E, and C treatment groups.

E2 concentrations were as expected being highest
(P<0.001) in the E and EP treatment groups and lowest in the
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remaining treatment groups (Table 2-2).

Estrogen and

progesterone concentrations during the steroid treatment
period are shown in Figures 2-lA and B, respectively.
RBP Ouantitation of Uterine Flushes:

The RBP content

of uterine flushes collected at the time of hysterectomy is
shown in Table 2-3.
due to treatment.

There were no differences in RBP values

There was blood contamination in several

of the uterine flushes (which were not used) and the degree
of blood contamination in the flushes analyzed was not
determined.

There was also a large standard error

associated with this data set.

RBP mRNA expression in uterine endometrium:

Steady

state expression of RBP mRNA was analyzed several ways.

Uterine expression of RBP in the uterine endometrium was
corrected for loading error with /3-actin (Figure 2-2A) and

oligo dT (Figures 2-2B and 2-3), and was analyzed using 10
(Figure 2-3) or 20 /xg (Figures 2-2A and B) total RNA loaded

onto nylon membranes.

The values obtained by loading 10 /xg

of RNA onto a membrane and correcting loading error with
oligo dT are those believed the most accurate, and were
used.

However all values are reported.

RBP mRNA values

corrected with jS-actin and oligo dT using 20 /ug total RNA

are shown in Table 2-4 and Table 2-5, respectively.

When

RBP values were corrected with /3-actin, the EP treatment

group was significantly higher (P<0.05) than the C group.
The P-treated group was greater (P<0.05) than the C group.
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Table 2-1.

P4 Concentrations due to Treatment at

Hysterectomy.
Treatment

P4 concentration

N

(ng/ml)
c

4

0.16+/-0.41''

p

2

1.56+/-0.59*

E

3

0.07+/-0.48''

EP

3

2.32+/-0.48*

D1

2

0.83+/-0.59*

"''Mean+/-S.E.; values with different superscripts
are significantly different p<0.05.

Table 2-2.

E2 Concentrations due to Treatment at

Hysterectomy.
Treatment

Ej concentration

N

(pg/ml)

C

4

2.97+/-5.20*

P

4

2.83+/-5.20''

E

2

69.50+/-7.35''

EP

2

65.73+/-7.35''

D1

2

4.19+/-7.35*

'••Mean+Z-S-E.; values with different superscripts
are significantly different p<0.001.

Table 2-3.

Total RBP in Uterine Flushes due to Treatment.

Treatment

N

RBP in uterine flush (ng)

C

4

581.5+/-225.0*

P

2

575.6+/-318.2'

E

1

752.1+/-0''

EP

2

1347.1+/-318.2*

D1

2

1238.3+/-318.2*

•Mean+/-S.E.; no significant differences found P>0.05.
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Table 2-4. Uterine endometrial expression of RBP mRNA
standardized with jS-actin. Values were obtained by loading
20 jLtg total RNA onto nylon membranes.
Treatment

RBP mRNA

N

(arbitrary units)
C

4

0.230+/-0.056'

P

3

0.417+/0.064*^

E

3

0.199+/0.064'

EP

3

0.480+/-0.064*

D1

2

0.247+/-0.079'"

•.b.cMean+Z-S.E.; values with different superscripts
are significantly different p<0.05.

Table 2-5.

Uterine endometrial expression of RBP mRNA

standardized with oligo dT.

Values were obtained by loading
RBP mRNA

Treatment

N

C

4

0.361+/-0.038*

P

3

0.447+/-0.044*

E

3

0.196+/-0.044''

EP

3

0.397+/-0.044''

D1

2

0.420+/-0.053*

(arbitrary units)

*''^ean+/-S.E.; values with different superscripts
are significantly different p<0.05.
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Figure 1.

Plasma Ej (A) and P4 (B) concentrations of

ovariectomized ewes on days 3 and 10 of steroid treatment
and on the day of hysterectomy.
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Day

10

Day

10

Hysterectomy

EP

E

c

P

Hysterectomy

EP

E

C

Figure 2. uterine endometrial expression of RBP mRNA
standardized with /3-actin (A) or oligo dT(B) (20 fig total
RNA loaded onto membranes).
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Table 2-6.

Uterine endometrial expression of RBP mRNA

standardized with oligo dT.

Values were obtained by loading

10 fjLg total RNA onto nylon membranes.
Treatment

RBP mRNA

N

(arbitrary units)
C

4

0.439+/-0.073*^

P

2

0.879+/-0.104*

E

3

0.264+/-0.085'*'

EP

2

0.541+/-0.104''

D1

3

0.244+/-0.085®

'"•'•'Mean +/-S.E.; values with different
superscripts are significantly different p<0.05.
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Figure 3.

Uterine endometrial expression of RBP mRNA

standardized with oligo dT (10 /xg total RNA loaded onto the
membrane).
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Estrogen-treated animals were significantly lower (P<0.05)
than all other treatment groups when RBP mRNA expression was
standardized with oligo dT (Table 2-5).

Steady state levels

of RBP mRNA corrected with oligo dT using 10 ^lg total RNA
are shown in Table 2-6 and Figure 3.

The P treatment group

was significantly higher (P<0.05) than the C group as can be
seen in Figure 2-3.

Ewes receiving EP treatment were

slightly higher than C ewes, but this difference was not
significant.

Discussion

This study was undertaken in order to better understand
the effects of individual steroids on uterine expression of
RBP mRNA.

The concentration of RBP secreted by the uterus

was determined in uterine flushes.

Due to high standard

error, no differences due to treatment were found.

Uterine

flushes were obtained before hysterectomy, and therefore

some degree of blood contamination was encountered.

Because

we could not be sure of how much blood was contained in each

sample, the values presented in Table 2-3 cannot be trusted.
Based on previous studies, ovariectomized gilts (Adams at

al., 1981) and cows (Thomas et al., 1992) treated with

progesterone had significantly higher levels of RBP in
uterine flushes compared to control levels.

Therefore, it

is plausible to speculate that similar results might have
been obtained in this experiment.
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The serum levels of steroids were consistent with
treatment in most cases.

If the serum levels of the

steroids did not correspond with its respective treatment,
the sample was not included in the results.

For

progesterone, samples were excluded if the levels were below
luteal concentrations (1.0 ng/ml).
samples.

This occurred in 2

Two samples from estrogen-ewes were excluded

because the silastic implants were not recovered at the end

of the experiment and the circulating levels of estradiol17j8 for these two samples were drastically lower than the
remaining estrogen-treated ewes.

Somewhat unexpectedly,

estrogen concentrations were much higher in the ewes treated
with estradiol-lVjS than what was expected.

The estrogen

implants used in this experiment were found to release
estrogen to maintain circulating concentrations at
approximately 3 pg/ml by Karsch et al. (1980).

Estrogen

concentrations of the estrogen-treated ewes in this study

had an average value of 65 pg/ml (Table 2).

This may

explain some of the results obtained for the levels of RBP
mRNA which will be discussed later.

Steady state levels of RBP mRNA were determined several

ways.

Correcting RBP expression with /3-actin did not result

in accurate RBP values since j8-actin expression changes

throughout the estrous cycle.

Alternatively, oligo dT was

used to represent total RNA and correct for loading error.
Initially, 20 fig total RNA was loaded onto membranes but
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this amount of RNA is close to saturation of the membrane.

Consequently, 10 fig total RNA was loaded onto the membrane.
Therefore, the results obtained using oligo dT to correct
for loading error and by applying 10 fig total RNA to nylon
membranes (Table 2-6 and Figure 3) will be used for the

purpose of discussion.

The results of this experiment

support the theory that progesterone inhibits endometrial
expression of RBP mRNA, and that long-term progesterone
treatment may have a negligible effect due to down-

regulation of the progesterone receptor.

According to this

hypothesis, progesterone negatively regulates RBP expression
early in the luteal phase (days 1-5).

After approximately

8-10 days of progesterone exposure, progesterone has been
shown to down-regulate the progesterone receptor (Spencer

and Bazer, 1995; Spencer et al., 1995b).

With this

mechanism in place, progesterone no longer can bind to and
form a complex with its receptor, and therefore cannot

inhibit expression of RBP mRNA within the uterus.
Studies that characterized expression of RBP mRNA

during the estrous cycle lend furhter support to this
theory.

During the estrous cycle in the ewe, levels of RBP

mRNA decrease at the beginning of the luteal phase (day 5)

when progesterone is being secreted by the corpus luteum,
increase to maximal expression at the end of the luteal

phase (days 13, 14), and are either maintained or slightly
decrease during the follicular phase (days 15-16) when
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estrogen levels are elevated (Harney et al., 1993; Dore et

al., 1994).

The increase in expression of RBP transcripts

at the end of the luteal phase (days 13, 14) coincides with
progesterone receptor down-regulation.

The numbers of

progesterone receptors increase during the follicular phase
(days 15-16) (Ott et al., 1993), due to increasing levels of
estrogen which up-regulate the progesterone receptor (Ing et
al., 1996; Spencer et al., 1995a).

Because progesterone

levels are low to undetectable during the follicular phase

due to luteolysis, progesterone is not available to bind to
its receptor and affect RBP expression.
levels of endometrial RBP mRNA

As a result, the

have been shown in previous

studies to remain the same or slightly decrease compared to
the levels obtained at the end of the luteal phase (Harney

et al., 1993; Dore et al., 1994).

In this study, ovariectomized ewes were administered

long-term treatment ( 13-16 days) of steroids.

Expression

of RBP mRNA was significantly higher in progesterone-treated

ewes than any other treatment (Figure 3).

Since ewes were

treated with 13-16 days of progesterone, the progesterone

receptor would have been down-regulated at this time, and

progesterone therefore no longer would inhibit RBP
expression.

The fact that RBP mRNA levels of progesterone-

treated ewes were actually greater than control levels was

somewhat surprising.

If long-term exposure to progesterone,

through down-regulation of its receptor, does not affect
65

expression of RBP, we would expect no difference between
progesterone treatment and controls, but long-term

progesterone had a stimulatory effect on RBP mRNA.

This

suggests that regulation of RBP gene expression is complex
and other factors besides the sex steroids may contribute to

the regulatory mechanism of RBP mRNA expression.
In ewes treated with estrogen and progesterone, the

levels of RBP mRNA were significantly lower than the levels

in progesterone-treated ewes, but not significantly
different than control levels.

Estrogen, in contrast to

progesterone, up-regulates expression of progesterone

receptors.

Therefore in ewes treated with progesterone and

estrogen, we would not expect progesterone receptors to

decrease as much as in progesterone-treated ewes allowing

some degree of inhibition of RBP expression to occur, and
hence the difference in expression of the two treatment
groups.

The day 1 control group exhibited levels of RBP mRNA
that were lower than controls, but this difference was not

significant.

In this group, the progesterone receptor would

begin to be down-regulated from the initial progesterone
treatment, and then steady state levels of RBP mRNA would
increase after administration of estrogen in the absence of

progesterone.

As a result, expression of endometrial RBP

transcripts would be somewhat inhibited.

However, it should

be pointed out that the results of this group are somewhat
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confounded because the day 1 controls were treated with 6 or
8 days of progesterone which may have caused some variation

within this group.
RBP mRNA expression in ewes treated with long-term
estrogen was lower than control ewes, but this difference

was not statistically significant.

In ovariectomized rats,

chronic exposure to estrogen actually decreased estrogen
receptors (Manni et al., 1981), whereas at lower doses,

estrogen increases estrogen receptor concentrations (Ing et
al., 1996).

In the present study, the plasma concentration

of estrogen was high and might be considered to be chronic

estrogen exposure which may have led to estrogen receptor
down-regulation.

Therefore, estrogen may not have exerted

its full effect in the estrogen-treated group and RBP
expression may have been significantly lower than controls

if circulating levels of estrogen had not been so high.
Interestingly, estrogen receptors have been localized

in the day 21 trophoblast (Wathes and Hamon, 1993).

At the

same time, levels of RBP mRNA peak during early pregnancy at
day 23 of gestation (Dore et al., 1994).

Low levels of

estrogen are present during early pregnancy, suggesting that
estrogen may up-regulate expression of RBP mRNA in the

conceptus by binding to its receptor found in the day 21
conceptus.

However it is not completely understood what the

short-term effects of estrogen are on expression of RBP.
It is probable that there are many other factors
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involved in the regulation of RBP mRNA besides the steroid
hormones.

Glover and coworkers (1976) have suggested that

gonadal hormones are not involved at all, since RBP is found

in ewes throughout the year and sheep exhibit an anestrous

period in which the gonads are quiescent.

In the present

study, detectable levels of RBP mRNA were found in control

ewes indicating that there must be other mechanisms of
control besides steroids.

Ovine interferon-T (oIFN-t) may play an indirect role
in regulating RBP expression.

oIFN-t is believed to be the

signal for maternal recognition of pregnancy and has been
found to decrease estrogen and oxytocin receptors thereby

inhibiting the luteolytic mechanism (Spencer et al., 1995a;
Spencer et al., 1995b).

This mechanism by which estrogen

receptors are inhibited may also ensure down-regulation of
the progesterone receptor enabling expression of endometrial

RBP mRNA to remain high during early pregnancy.

In conclusion, this study lends support to the theory
that long-term progesterone stimulates uterine expression of

RBP mRNA by down-regulating its own receptor thereby
negating inhibition of RBP mRNA expression caused by shortterm progesterone exposure as seen on day 5 of the estrous

cycle.

The results also suggest that long-term estrogen

treatment may inhibit RBP mRNA.

Future studies involving

short-term steroid treatment will be needed to prove this
theory.
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1.

ELISA buffers.

Diluent
100 ml 10% BSA
90 ml lOX PBS
5 ml 10% Tween 20

5 mg Bromphenol blue

Bring to 1 L with water.

lOX TBS

350.64 g NaCl
96.88 g Trizma Base
8.0 g sodium azide

Adjust pH to 7.4.

Bring to 4 L with water.

Wash buffer
400 ml lOX TBS
20 ml 10% Tween 20

Bring to 4 L with water.

2.

Prehybridization and hybridization buffers used with RBP

probe and j3-actin probe (20 /xg total RNA loaded onto

membrane).

Prehybridization buffer
5X SSPE

2X Denhardt's
0.2% SDS

100 /ig/ml yeast RNA

Hybridization buffer
5X SSPE
IX Denhardt's
0.1% SDS

100 /Ltg/ml yeast RNA
50% formamide

82

3.

Wash procedure used with RBP probe and jS-actin probe (20

Hg total RNA loaded onto membranes).

Time
5 minutes
5 minutes
5 minutes
15 minutes
20 minutes

Wash buffer

2X SSPE/0.1% SDS
2X SSPE/0.1% SDS
IX SSPE/0.1% SDS
IX SSPE/0.1% SDS
O.IX SSPE/0.1% SDS

Temperature

room temperature
room temperature
room temperature
65®C
65»C

4. Prehybridization and hybridization buffer used with
oligo dT probe (20 ng total RNA loaded onto membrane).

Prehybridization and Hybridization buffer
5X SSPE

5% Dextran sulfate
5X Denhardt's

1 mM EDTA, pH 7.5
0.1 mg/ml tRNA
0.1% SDS

5.

Wash procedure used with oligo dT probe (20 ng total RMA

loaded onto membrane).

Wash buffer
5X
5X
5X
5X

SSPE/0.1% SDS
SSPE/0.1% SDS
SSPE/0.1% SDS
SSPE/0.1 % SDS

Time
15 minutes
15 minutes
15 minutes
15 minutes

83

Temperature
37°C in roller bottle
37»C in roller bottle

3700
37°C

in plastic container
in plastic container

6. Prehybridization and hybridization buffer used with
oligo dT probe (10 /xg total RNA loaded onto membrane).

Prehybridization and Hybridization buffer
50% formamide
5X SSPE

5% Detran sulfate

pH mixture to 7-7.5
5X Denhardt's
0.1% SDS

0.1 mg/ml sheared salmon sperm ssDNA

7.

Wash procedure used with oligo dT probe (10 ng total RNA

loaded onto membrane).

Wash buffer

5X SSPE/0.1% SDS
5X SSPE/0.1% SDS
IX SSPE/0.1% SDS
O.IX SSPE/0.1% SDS
O.IX SSPE/0.1% SDS

Time
15 minutes
15 minutes
15 minutes
15 minutes
30 minutes
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Temnerature
42®C in roller bottle
42®C

in roller bottle

42<'C in
65°C in
65°C in

plastic container
plastic container
plastic container
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